North America Pharmaceutical Contract Manufacturing Market 2022 Global Competition and Business Outlook - Catalent Inc., Recipharm AB, Jubilant Life Sciences Ltd, Thermo Fisher Scientific Inc

Market Insights Reports has added new statistical data to its repository titled as, Global North America Pharmaceutical Contract Manufacturing Market. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). Furthermore, the report also sheds light on technological platforms, in addition to distinctive tools, and methodologies that will help to propel the performance of industries. The North America Pharmaceutical Contract Manufacturing market report covers the post-COVID-19 impact on various regions and major countries and on the future development of the industry is pointed out.

The North America Pharmaceutical Contract Manufacturing Market was valued at USD 45.13 billion is expected to reach USD 62.04 billion at a CAGR of 5.2% over the forecast period from 2021 - 2026.

 (Avail a Flat 25% discount on this report)

Click the link to get a Free Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/02082592069/north-america-pharmaceutical-contract-manufacturing-market-growth-trends-covid-19-impact-and-forecasts-2021-2026/inquiry?Mode=A28                               

Top Key Players in the Global North America Pharmaceutical Contract Manufacturing Market is Catalent Inc., Recipharm AB, Jubilant Life Sciences Ltd, Thermo Fisher Scientific Inc. (Patheon Inc.), Boehringer Ingelheim Group, Pfizer CentreSource (Pfizer Inc.), Aenova Group, AbbVie, Inc., Baxter Biopharma Solutions (Baxter International Inc.), Lonza Group AG, Siegfried AG, and others. 

Industry News and Update:

- May 2020 - Arcturus Therapeutics Holdings Inc. and Catalent, Inc. announced a partnership to support the expected manufacture of Arcturus' COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to protect against the SARS-CoV-2 coronavirus. The production of LUNAR-COV19 at Catalent's state-of-the-art drug substance biomanufacturing facility in Madison, Wisconsin, will support human clinical studies and, if successful, commercialization of the vaccine.

- May 2020 - AbbVie announced that the U.S. Federal Trade Commission (FTC) had accepted the proposed consent order in connection with AbbVie's pending acquisition of Allergan. The acceptance by the FTC satisfies all required antitrust clearances needed to be obtained for the acquisition of Allergan by AbbVie.

Key Market Trends:

Finished Dosage Formulation (FDF) Development and Manufacturing is Expected to Witness Significant Growth

- The International Society of Aesthetic Plastic Surgery reported that with 4,361,867 cases, the United States ranked first in the total number of cosmetic procedures, in 2018. As of 2019, of those surveyed by the American Society for Dermatologic Surgery (ASDS), 70% were somewhat to extremely bothered by the lines and wrinkles around the eyes and led them to cosmetic procedures. The ASDS also stated that the demand for cosmetic surgery products is expected to rise in the United States, with injectables as the most significant and fastest-growing segment in the market.
- The US FDA later approved the use of injectable dermal fillers based on the review of data collected from controlled clinical studies that evaluated the safe and effective use of wrinkle fillers when injected into particular areas of facial tissue. Additionally, botox injections have increased in the country over the years. Moreover, according to the American Academy of Cosmetic Dentistry's Cosmetic Dentistry State of the Industry Survey, there was an increase in the number of patients seeking cosmetic dentistry and a rise in the average production per cosmetic patient per visit. This has also driven the demand for facial dentistry in the country.
- Baxter also acquired Claris injectables Ltd and gained complete access to the Claris Injectables product portfolio. Meitheal Pharmaceuticals Inc., a generic injectables company, got the US FDA approval for Enoxaparin Sodium Injection, USP, the generic equivalent of Lovenox. The company licensed Enoxaparin Sodium Injection exclusively through its partnership with Nanjing King-friend Biochemical Pharmaceutical Co. Ltd. Additionally, according to ICRA Limited, injectables drugs worth USD 16 billion went off-patent in the United States alone. The United States is witnessing a rise in demand for generic injectables, on account of increasing investment by the US Government for the development of generic drugs.

Full Browse the report description and TOC:

https://www.marketinsightsreports.com/reports/02082592069/north-america-pharmaceutical-contract-manufacturing-market-growth-trends-covid-19-impact-and-forecasts-2021-2026?Mode=A28            

This Global North America Pharmaceutical Contract Manufacturing Market report addresses:

– The Market size from 2016-2021

– Expected market growth until 2026

– Forecast of how market drivers, restraints, and future opportunities will affect

– Segment and regions that will drive or lead the market growth and why

– Comprehensive mapping of the competitive landscape

– In-depth analysis of key sustainability strategies adopted by market place.                              

Frequently Asked Questions about Global North America Pharmaceutical Contract Manufacturing market:

– What are the recent developments and government policies?
– Why might we forecast a downturn in a particular economy next year?
– Why do we say the currency is set to appreciate?
– What countries and sectors offer the highest potential?
– Where are the greatest dangers?              

We Also Offer Customization on report based on specific client Requirements:

– Free Country Level analysis for any 5 countries of your choice.

– Free Competitive analysis of any 5 key market players.

–  Free 40 analyst hours to cover any other data point

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides Global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.